Oviva has raised 21 million dollars in a financing round. The startup from the Greater Zurich Area uses technology-supported nutrition advice to fight illnesses such as Type 2 diabetes.

Oviva has successfully closed a series B financing round that raised 21 million dollars, announced a statement. The round was led by MTIP, a Basel investment company that specializes in healthcare technology. The German venture capital company Earlybird and current investors were also involved. 

Offering technology-supported medical nutrition advice, Oviva works with its own network of nutritional therapists and an innovative consulting technology. Users then get personalized advice via their mobile phone. The startup’s solution is designed to fight illnesses such as Type 2 diabetes and obesity-related conditions, and is currently used by 90,000 patients across Switzerland, Germany, France, the UK and the United Arab Emirates. The figure has consistently doubled each year for the last three years.

The new financing allows the company to roll out its expansion across Europe and further develop the underlying technology, according to co-founder and CEO Kai Eberhardt. Oviva was founded in 2014 and is headquartered in Altendorf. The latest financing round brings the total amount raised by Oviva to date to 34 million dollars.

Contact us

Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center? Give us a call or drop us a line. 

+41 44 254 59 59